We are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options.
$20.00 - $22.00
May 9, 2019
GOLDMAN SACHS & CO. LLC , LEERINK SWANN & COMPANY
To view the prospectus for Axcella Health IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253